基础疾病与脓毒症集束化治疗执行情况对高龄脓毒症患者的影响:一项全国性队列研究
该研究基于韩国脓毒症联盟数据库前瞻性收集的成人脓毒症患者,开展全国性队列研究,分析≥80岁高龄脓毒症患者的基础疾病、预后及其与脓毒症集束化治疗依从性的关联。在11,981例脓毒症患者中,3,733例(31.2%)为≥80岁高龄患者。院内生存者(69.8%)更年轻、男性比例更低、BMI更高、Charlson合并症指数更低、临床衰弱量表评分更低、SOFA评分更低;院内生存组乳酸测量率更低,但1小时集束化治疗中液体治疗和血管活性药物使用率更高,3小时和6小时集束化治疗中呈相似趋势;院内生存者24小时内接受适当经验性抗生素的比例更高。院内死亡与年龄、临床衰弱量表、SOFA评分、合并症、生命支持治疗问题、ICU干预及1小时脓毒症集束化治疗中血管活性药物使用相关。作者认为,处理基础疾病并提高脓毒症集束化治疗依从性对改善高龄脓毒症患者预后至关重要,需要个体化方法和提高认识,并应进一步研究优化该人群脓毒症治疗的干预措施。
要点
- 在11,981例脓毒症患者中,3,733例(31.2%)为≥80岁高龄患者,院内生存率为69.8%。
- 院内生存者更年轻、男性比例更低、BMI更高、Charlson合并症指数更低、临床衰弱量表评分更低、SOFA评分更低。
- 院内生存组乳酸测量率更低,但1小时集束化治疗中液体治疗和血管活性药物使用率更高,3小时和6小时集束化治疗中呈相似趋势。
- 院内生存者24小时内接受适当经验性抗生素的比例更高。
- 院内死亡与年龄、临床衰弱量表、SOFA评分、合并症、生命支持治疗问题、ICU干预及1小时脓毒症集束化治疗中血管活性药物使用相关。
适用人群与场景
- 成人脓毒症患者,数据来自韩国脓毒症联盟数据库,前瞻性收集;其中≥80岁定义为高龄患者。
研究设计与关键结果
- 研究类型:全国性队列研究;样本量:11,981例脓毒症患者,其中≥80岁高龄患者3,733例(31.2%)。
- 院内生存者占69.8%,其年龄更轻、男性比例更低、BMI更高、Charlson合并症指数更低、临床衰弱量表评分更低、SOFA评分更低。
- 院内生存组乳酸测量率更低,但1小时集束化治疗中液体治疗和血管活性药物使用率更高;3小时和6小时集束化治疗中呈相似趋势。
- 院内生存者24小时内接受适当经验性抗生素的比例更高。
- 院内死亡与年龄、临床衰弱量表、SOFA评分、合并症、生命支持治疗问题、ICU干预及1小时脓毒症集束化治疗中血管活性药物使用相关。
证据类型、等级与局限
- 证据类型:全国性前瞻性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,处理基础疾病并提高脓毒症集束化治疗依从性对改善高龄脓毒症患者预后至关重要。
- 作者认为,需要个体化方法和提高认识。
- 作者建议,进一步研究应探索优化该人群脓毒症治疗的干预措施。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Sepsis is a life-threatening condition that affects individuals of all ages; however, it presents unique challenges in very old patients due to their complex medical histories and potentially compromised immune systems. This study aimed to investigate the influence of underlying conditions and the performance of sepsis bundle protocols in very old patients with sepsis.
METHODS: We conducted a nationwide cohort study of adult patients with sepsis prospectively collected from the Korean Sepsis Alliance Database. Underlying conditions, prognosis, and their association with sepsis bundle compliance in patients with sepsis aged ≥ 80 years were analyzed.
RESULTS: Among the 11,981 patients with sepsis, 3,733 (31.2%) were very old patients aged ≥ 80 years. In-hospital survivors (69.8%) were younger, less likely male, with higher BMI, lower Charlson Comorbidity Index, lower Clinical Frailty Scale, and lower Sequential Organ Failure Assessment (SOFA) scores. The in-hospital survivor group had lower lactate measurement but higher fluid therapy and vasopressor usage within the 1-h bundle. Similar trends were seen in the 3-h and 6-h bundles. Furthermore, in-hospital survivors were more likely to receive appropriate empiric antibiotics within 24 h. In-hospital mortality was associated with age, Clinical Frailty Scale, SOFA score, comorbidities, Life sustaining treatment issue, interventions in the ICU and vasopressor use in the 1-h sepsis bundle.
CONCLUSIONS: Addressing underlying conditions and enhancing sepsis bundle adherence is crucial for better outcomes in very old patients with sepsis. Personalized approaches and increased awareness are essential. Further research should explore interventions to optimize sepsis care in this population.
参考来源
- Kim DK, Kim S, Kang DH, et al. Influence of underlying condition and performance of sepsis bundle in very old patients with sepsis: a nationwide cohort study. Ann Intensive Care. 2024. PMID: 39630376. doi:10.1186/s13613-024-01415-x
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。